Evidence map›Paper›PMID 28074251›Full record

ReviewOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2017

Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?

J C Ayus, T Bellido, A L Negri

Open access · greenAbstract readReview
In one paragraph

Review in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Association of hyponatremia with bone mineral density and fractures: a narrative review.Therapeutic advances in endocrinology and metabolism · 2023
    Review
  5. Article
  6. Hyponatremia and falls.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  7. The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  8. Article
  9. Adverse bone effects of medications used to treat non-skeletal disorders.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

J C AyusRenal Consultants of Houston, 2412 Westgate Street, Houston, TX, 77019, USA. carlosayus@yahoo.com.
T BellidoDepartment of Anatomy and Cell Biology, and Department of Medicine, Division of Endocrinology, Roudebush Veteran Administration Medical Center, Indiana University School of Medicine, Indianapolis, IN, USA.
A L NegriInstituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, Argentina.
Retina Consultants of Houston · USRichard L. Roudebush VA Medical Center · USUniversidad del Salvador · AR

Funding

TRANSGENIC MOUSE COREP01AG013918 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI MANOLAGAS, STAVROS C. · 1996 to 2016
$25.7M
Contribution of Osteocytes to the Musculoskeletal Effects of Multiple MyelomaR01CA209882 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI Teresita M. Bellido, Jesus Delgado-Calle · 2017 to 2026
$3.8M
Glucocorticoid-induced Atrophy in Bone and MuscleR01AR059357 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI BELLIDO, TERESITA M. · 2011 to 2022
$3.4M
CYTOKINE SIGNAL TRANSDUCTION IN OSTEOBLASTIC CELLSK02AR002127 · NIAMS · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI BELLIDO, TERESITA M · 2000 to 2004
$383k
BLRD VA I01 BX002104BLRD VA IK6 BX004596NCI NIH HHS R01 CA209882NIAMS NIH HHS K02 AR002127NIAMS NIH HHS R01 AR059357NIA NIH HHS P01 AG013918
6 · The paper itself

Abstract

The Fracture Risk Assessment Tool (FRAX®) was developed by the WHO Collaborating Centre for metabolic bone diseases to evaluate fracture risk of patients. It is based on patient models that integrate the risk associated with clinical variables and bone mineral density (BMD) at the femoral neck. The clinical risk factors included in FRAX were chosen to include only well-established and independent variables related to skeletal fracture risk. The FRAX tool has acquired worldwide acceptance despite having several limitations. FRAX models have not included biochemical derangements in estimation of fracture risk due to the lack of validation in large prospective studies. Recently, there has been an increasing number of studies showing a relationship between hyponatremia and the occurrence of fractures. Hyponatremia is the most frequent electrolyte abnormality measured in the clinic, and serum sodium concentration is a very reproducible, affordable, and readily obtainable measurement. Thus, we think that hyponatremia should be further studied as a biochemical risk factor for skeletal fractures prediction, particularly those at the hip which carries the greatest morbidity and mortality. To achieve this will require the collection of large patient cohorts from diverse geographical locations that include a measure of serum sodium in addition to the other FRAX variables in large numbers, in both sexes, over a wide age range and with wide geographical representation. It would also require the inclusion of data on duration and severity of hyponatremia. Information will be required both on the risk of fracture associated with the occurrence and length of exposure to hyponatremia and to the relationship with the other risk variables included in FRAX and also the independent effect on the occurrence of death which is increased by hyponatremia.

Indexed as

Accidental FallsAlgorithmsGaitHumansHyponatremiaOsteoporotic FracturesRisk AssessmentRisk FactorsFracturesFRAXHyponatremiaOsteoporosisRisk assessment

Identifiers

PMID28074251
PMCPMC10900869
OpenAlexW2567868122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.